Oral Rehydration Salts Market by Form (Capsules, Powder, Tablets), Age Group (Adult, Infant), Distribution - Global Forecast 2024-2030

Oral Rehydration Salts Market by Form (Capsules, Powder, Tablets), Age Group (Adult, Infant), Distribution - Global Forecast 2024-2030

The Oral Rehydration Salts Market size was estimated at USD 3.08 billion in 2023 and expected to reach USD 3.33 billion in 2024, at a CAGR 8.31% to reach USD 5.38 billion by 2030.

Oral rehydration salts (ORS) are a scientifically formulated mixture of glucose, salts, and minerals designed to restore the body's essential electrolytes and fluids. These compounds are generally dissolved in a specific amount of clean water and used to prevent or treat dehydration, particularly owing to diarrhea. The solution's osmolarity and electrolyte concentrations are meticulously aligned with the body's needs to facilitate rapid and efficient absorption both in the small intestine and the systemic circulation. ORS has been proven to be a highly effective, safe, and economical intervention in the management of dehydration, especially in cases of acute gastroenteritis and cholera. The oral rehydration salts market’s growth is propelled by heightened awareness, urgent relief needs for dehydration, and scientific advancements in the formulation of ORS. The oral rehydration salts market encounters hurdles regarding counterfeit products and product recall incidents. However, new product innovations focused on taste and convenience, signaling a robust potential for the global oral rehydration salts market growth.

Regional Insights

In the United States and Canada, oral rehydration salts (ORS) is commonly available and widely used, primarily as an over-the-counter remedy for dehydration caused by gastroenteritis, hangovers, or physical exertion. Consumers in these countries prefer flavored and branded ORS, perceived as being of higher quality. Moreover, these regions have a growing trend of using ORS for sports and fitness purposes. In South America, there is a significant need for ORS due to the prevalence of diseases causing dehydration. Public health programs often distribute ORS freely to address these issues. In Europe, Germany boasts a well-established pharmaceutical industry which acts as a driver for the ORS market. The country's strong emphasis on clinical research and development has led to the introduction of enhanced ORS solutions. The EU's stringent regulatory environment ensures that the ORS sold within its market is safe and effective. Customer purchasing behavior leans towards trusted brands with established efficacy. In the Middle East, ORS usage is associated with conditions such as heatstroke and dehydration due to the high temperatures and arid climate. Africa represents a vast market for ORS due to the high prevalence of diseases like cholera and diarrheal illnesses, particularly among children. The need for ORS is acute in regions with limited clean water and sanitation facilities. International aid organizations, along with local governments, often support the distribution of ORS to prevent dehydration-related deaths. The Asia Pacific region exhibits a significant demand for Oral Rehydration Salts (ORS), primarily driven by countries such as China, Japan, and India, as these countries have high incidences of diarrheal diseases due to factors such as water pollution and poor hygiene practices. Consumer awareness about the benefits of ORS in preventing dehydration is substantial because of various government and non-governmental health initiatives.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Oral Rehydration Salts Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increased prevalence of diarrhea among population
Increased commercialization and product availability in online and offline pharmacies
Rising awareness regarding dehydration and need for easy treatment

Market Restraints

Preference towards home-made alternatives and product recall incidences associated with oral rehydration salt products

Market Opportunities

Product innovation in terms of flavor and nutrition value
Advancements in production and packaging of oral rehydration salts

Market Challenges

Issues associated with counterfeit products and unmonitored side effects associated with overconsumption of ORS

Market Segmentation Analysis

Form: High preferences for powders in managing dehydration due to their versatility and cost-effectiveness
Age Group: Increasing usage of ORS among adults to cure diarrhea and dehydration
Distribution: Rising preferences for pharmacies to purchase ORS

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Oral Rehydration Salts Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Oral Rehydration Salts Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Otsuka Pharmaceutical Factory launches additional OS-1 Apple Flavor 300 mL and 500 mL to the Oral Rehydration Solution OS-1 series

Otsuka Pharmaceutical Factory, Inc., renowned for its expertise in intravenous solutions, is innovating within the field of Oral Rehydration Therapy (ORT) with the introduction of OS-1 Apple Flavor, expanding its OS-1 series on July 4. This new flavor offers the same effective electrolyte and water replenishment as the original, now coupled with an appealing apple taste, and has been recognized as a food for special dietary use for medical conditions by Japan's Consumer Affairs Agency. Coinciding with this launch, OPF is unveiling a new 300-mL PET bottle designed for ergonomic ease of handling, while phasing out the traditional 280-mL bottle to enhance consumer convenience.

UFlex–Asepto equips FDC’s Oral Rehydration Salts brand with holographic packs in India

In an innovative collaboration, FDC has joined forces with UFlex–Asepto, India's pioneering aseptic liquid packaging manufacturer, to introduce a novel packaging solution for its Electral Z+ (ORS + Zinc Solution) ready-to-drink product produced by Halewood Laboratories Private. UFlex–Asepto's holographic packs provide interactive visual appeal and ensure product differentiation for the Electral Z+ brand.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Oral Rehydration Salts Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Oral Rehydration Salts Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, AstraEureka Pharmaceuticals, Cera Products Inc., Cian Healthcare Limited, Cipla Limited, Clinova Limited, FDC Limited, H2ORS, Inc., Halewood Laboratories Pvt. Ltd., Healthy Life Pharma Pvt. Ltd., Hind Pharma, KBI Pharmaceuticals GmbH & Co. KG, Niksan Pharmaceutical, Nutriset, Otsuka Pharmaceutical Co., Ltd., Phaedrus Life Science Pvt. Ltd, Pharma Biological, Shereya Life Sciences Pvt. Ltd., SK Agro Foodtech Pvt. Ltd., Trifecta Pharmaceuticals USA, LLC, Velnex Medicare, Wallace Pharma, Weefsel Pharma, and Wellona Pharma.

Market Segmentation & Coverage

This research report categorizes the Oral Rehydration Salts Market to forecast the revenues and analyze trends in each of the following sub-markets:

Form
Capsules
Powder
Tablets
Age Group
Adult
Infant
Distribution
Convenience Stores/Supermarkets
Health Centres
Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year